- Filed
- Feb 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Feb 6, 2025 | 2.02M sh |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $7.2M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $67.6M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $149.16M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $142.44M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $311.93M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $302.75M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 2.07M sh |
| Stock Repurchased | Q1 2025 · Dec 31, 2023 | $538.57K |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | $6.75M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $150.7M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $146.71M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $2.19 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $2.19 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $325.06K |
| Net Income restated | Q1 2025 · Dec 31, 2023 | $4.53M |